ADTX Aditxt Corp: Multiplikator Forward P/S
Aditxt is expanding its ecosystem through mergers with biotech startups, yet a critical liquidity shortage and mounting debt threaten the holding company's stability. Data from the GURU.Markets terminal provides a calculated forward P/S, where the 1017.10 figure serves as the target level. Meanwhile, patents in immune monitoring provide Aditxt with the potential to monetize intellectual property through clinical ancillary services.
Rincian analitis perusahaan aditxt.com (ADTX)
- rega saiki lan proyeksi nilai saham:
- data kapitalisasi saham perusahaan:
- statistik nilai buku emiten:
- indikator beban kredit lan likuiditas emiten:
Rasio Total Utang marang Ekuitas Aditxt|ADTX - Rasio silihan jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Aditxt, Inc.|ADTX - Utang agregat perusahaan|Utang marang nilai buku Aditxt, Inc.|ADTX - Gedhene kewajiban jangka dawa|Utang jangka cendhak perusahaan Aditxt|Rasio cepet aditxt.com
- rincian asil keuangan lan kelipatan valuasi:
ADTX - Bathi perusahaan|Bathi mangsa ngarep Aditxt|ADTX - Rasio rega pasar marang bathi resik|Prakiraan rega marang bathi Aditxt, Inc.|ADTX - Rasio P/E diaturake wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Aditxt, Inc.|ADTX - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi resik saben saham (EPS TTM) Aditxt|ADTX - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan aditxt.com|ADTX - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Aditxt
- indikator dodolan lan pendapatan:
Pambiji fundamental perusahaan:Aditxt Corp (ADTX)
The efficiency of the Pears platform in monitoring immune rejection during transplants determines the revenue growth rates of Aditxt, which directly impacts the forward P/S as the ratio of market capitalization to expected sales. By analyzing the Aditxt forward P/S chart, an investor assesses the degree of overpayment for future income, utilizing multiple compression to identify entry points into an undervalued asset.
Perusahaan pesaing
Multiplikator Forward P/S ARGX (argenx)|BioNTech Inc. (BNTX) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Abivax Corp - Multiplikator Forward P/S|ADMA - Multiplikator Forward P/S|PTGX: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan IMVT|KNSA (Kiniksa) - Multiplikator Forward P/S|Grifols SA (GRFS) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan ADPT (Adaptive Biotechnologies Corp)|Rasio rega marang pendapatan sing dikarepake CLDX|Aurinia Pharmaceuticals - Multiplikator forward rega marang pendapatan|BCRX: Kapitalisasi marang prakiraan pendapatan|VERA: Multiplikator forward rega marang pendapatan|Dianthus Therapeutics Inc - Rasio rega marang pendapatan sing dikarepake|PHVS: Multiplikator Forward P/S|AbCellera Corp (ABCL) - Multiplikator Forward P/S|TRML (Tourmaline Bio, Inc.) - Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PGEN (precigen.com)|Multiplikator forward rega marang pendapatan PHAR (Pharming Group)|Rasio rega marang pendapatan sing dikarepake NKTR|Upstream Bio Corp - Multiplikator forward rega marang pendapatan|ZBIO: Kapitalisasi marang prakiraan pendapatan|IMNM - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan GOSS|KALV: Multiplikator Forward P/S|Septerna, Inc. - Rega forward marang dodolan|PVLA (Pieris Pharmaceuticals Inc) - Multiplikator Forward P/S|Multiplikator Forward P/S Savara Pharma|Rasio rega marang prakiraan pendapatan Rigel Pharmaceuticals (RIGL)|ANAB (anaptysbio.com) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Astria Therapeutics, Inc. ATXS|ENGN - Multiplikator forward rega marang pendapatan|RAPT Therapeutics, Inc. - Multiplikator Forward P/S|JBIO - Multiplikator Forward P/S|ACRS (Aclaris Therapeutics) - Multiplikator forward rega marang pendapatan|kyvernatx.com - Rega forward marang dodolan|TLSA (Tiziana Life Sciences Ltd) - Multiplikator Forward P/S|Cabaletta Bio Inc. (CABA) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Ventyx Bio (VTYX)|Multiplikator forward rega marang pendapatan Theratechnologies, Inc THTX|Rasio rega marang prakiraan pendapatan Avalo Therapeutics, Inc AVTX|ELDN - Multiplikator forward rega marang pendapatan|AGEN: Multiplikator forward rega marang pendapatan|CLYM - Multiplikator Forward P/S|Zura Bio Limited (ZURA) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan ATYR|ADAG (Adagene Inc) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Ikena Oncology, Inc. IMA|Multiplikator Forward P/S STTK|Multiplikator Forward P/S equilliumbio.com (EQ)|Multiplikator Forward P/S CNTB (Connect Biopharma Holdings Limited)|IMUX: Kapitalisasi marang prakiraan pendapatan|Atara Biotherapeutics Inc - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake InflaRx N.V. IFRX|XFOR (X4 Pharmaceuticals, Inc.) - Multiplikator forward rega marang pendapatan|ACET: Rasio rega marang pendapatan sing dikarepake|Multiplikator forward rega marang pendapatan CELU|Kapitalisasi marang prakiraan pendapatan INMB (INmune Bio Corporation)|Multiplikator forward rega marang pendapatan BRNS (Barinthus Biotherapeutics)|Rasio rega marang pendapatan sing dikarepake KZR|Multiplikator Forward P/S SABS (SAB Biotherapeutics, Inc.)|Multiplikator Forward P/S Akari Therapeutics PLC AKTX|Enlivex Therapeutics, Ltd. - Multiplikator Forward P/S|QTTB (Q32 Bio Inc.) - Kapitalisasi marang prakiraan pendapatan|GOVX (GeoVax Labs, Inc.) - Multiplikator forward rega marang pendapatan|EDSA: Rasio rega marang pendapatan sing dikarepake|Multiplikator forward rega marang pendapatan IBIO|Kapitalisasi marang prakiraan pendapatan CARM (Carisma Tx)|Rasio rega marang prakiraan pendapatan XTL Biopharmaceuticals, Ltd. (XTLB)|BOLT: Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S HCWB (HCW Biologics)|Rega forward marang dodolan APVO|AIM ImmunoTech - Multiplikator Forward P/S|GRI - Multiplikator Forward P/S|XORTX (XRTX) - Rasio rega marang prakiraan pendapatan|Vyome Therapeutics - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Revelation Biosciences|Multiplikator forward rega marang pendapatan indaptusrx.com (INDP)|Multiplikator Forward P/S SCNI|Multiplikator Forward P/S calcimedica.com (CALI)|Affimed N.V. - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan ALLK|HOOKIPA - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake IGM Biosciences, Inc. IGMS|iTeos Therapeutics, Inc. (ITOS) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Ocean Biomedical Inc|Rasio rega marang prakiraan pendapatan TC BioPharm (Holdings) PLC|Multiplikator forward rega marang pendapatan Third Harmonic Bio Inc (THRD)
